Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 1/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 3/20 | 0.41 |
| ▸ | PDE2A | O00408 | 4/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.39 |
| ▸ | MOGAT2 | Q3SYC2 | 3/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23668181 | 0.84 | MTNR1A (0.42) | MTNR1AMTNR1BMAOA | |
| SCHEMBL23668188 | 0.80 | HRH3 (0.52) | — | |
| SCHEMBL21834277 | 0.78 | MAOB (0.41) | MAOBPDE2ACYP2C9MOGAT2MAOA | |
| SCHEMBL21834279 | 0.78 | MAOB (0.41) | MAOBPDE2ACYP2C9MOGAT2MAOA | |
| SCHEMBL21834275 | 0.78 | MAOB (0.41) | MAOBPDE2ACYP2C9MOGAT2MAOA | |
| SCHEMBL21834361 | 0.74 | GPR88 (0.39) | MAOBPDE2AMOGAT2MAOAGRIN1 | |
| SCHEMBL21834262 | 0.73 | MAOB (0.39) | MAOBPDE2ACYP2C9MOGAT2MAOA | |
| SCHEMBL21834244 | 0.73 | PDE2A (0.42) | MAOBPDE2ACYP2C9MOGAT2MAOA | |
| SCHEMBL21834345 | 0.72 | CYP2D6 (0.39) | MAOBPDE2AMAOAGRIN1GRIN2B | |
| SCHEMBL23668189 | 0.71 | GRIN1 (0.39) | MTNR1AMTNR1BMAOBGRIN1GRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3854788-A1 | COMPOUND CONTAINING OXADIAZOLE, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | SK Biopharmaceuticals Co., Ltd. (KR) | 2021-07-28 | — | — | EP | claimed |
| EP-3854788-A1 | COMPOUND CONTAINING OXADIAZOLE, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | SK Biopharmaceuticals Co., Ltd. (KR) | 2021-07-28 | — | — | EP | disclosed |